BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Life Medical Sciences (CHAI) Receives Additional State Funding


10/19/2005 5:12:32 PM

OCEANPORT, N.J., Jan. 20 /PRNewswire-FirstCall/ -- Life Medical Sciences, Inc. (Bulletin Board OTC: CHAI.OB), today announced that it received approximately $300,000 through the sale of certain accumulated state tax net operating losses. The Company has participated in the Technology Business Tax Certificate Transfer Program administered by the Economic Development Authority of the State of New Jersey since the inception of the program in 1999 during which time the Company has received a total of $2.3 million in grants. Participating companies in this program are competitively chosen based, in part, on their being recognized as emerging high technology companies and their potential economic benefit to the state through the creation of jobs and the enhancement to the state's reputation as a center for emerging high technology.

Life Medical Sciences, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products. The Company is developing a broad range of bioresorbable polymer products to prevent/reduce post-operative adhesion formation.

Certain statements in this Press Release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Reference is made to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2003 for a description of some of these risks and uncertainties.

Life Medical Sciences, Inc.

CONTACT: Robert P. Hickey of Life Medical Sciences, Inc.,+1-732-728-1769, rhickey@lifemedicalsciences.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES